过去一年中添加的文章，按日期排序

1886-LB: Safety, PK, and Preliminary Efficacy of the Liver-Targeted Mitochondrial Protonophore TLC-6740—A Phase 1 Study

…, S WENG, BJ KIRBY, A SHAH, GI SHULMAN… - Diabetes, 2024 - Am Diabetes Assoc
36 天前 - … in a dose-dependent manner with no impact of food or body weight. TLC-6740 caused
significant, dose-dependent reductions … , supporting its potential for treatment of obesity. …
相关文章